Dietary bioflavonoids induce apoptosis in human leukemia cells

Leukemia Research

Volumn 29, Issue 5, 2005, Pages 573-581

  Matsui, Jun ^a   Kiyokawa, Nobutaka ^a   Takenouchi, Hisami ^a   Taguchi, Tomoko ^a   Suzuki, Kyoko ^a   Shiozawa, Yusuke ^a   Saito, Masahiro ^a   Tang, Wei Ran ^a   Katagiri, Yohko U ^a   Okita, Hajime ^a   Fujimoto, Junichiro ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Acute lymphoblastic leukemia; Apoptosis; Bioflavonoid; Precursor B cell

Indexed keywords

APIGENIN; BIOFLAVONOID; CASPASE; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; FISETIN; FLAVONE; GENISTEIN; GENISTIN; LUTEOLIN; QUERCETIN; RUTOSIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

EID: 20044394164     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.11.015     Document Type: Article

References (24)

1. B. Havsteen Flavonoids, a class of natural products of high pharmacological potency Biochem Pharmacol 32 1983 1141 1148
2. E. Wollenweber Occurrence of flavonoid aglycones in medicinal plants Prog Clin Biol Res 280 1988 45 55
3. V. Cody Crystal and molecular structures of flavonoids Prog Clin Biol Res 280 1988 29 44
4. R. Vrijsen, L. Everaert, and A. Boeye Antiviral activity of flavones and potentiation by ascorbate J Gen Virol 69 1988 1749 1751
5. B. Mittra, A. Saha, A.R. Chowdhury, C. Pal, S. Mandal, and S. Mukhopadhyay Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis Mol Med 6 2000 527 541
6. M. Yoshida, T. Sakai, N. Hosokawa, N. Marui, K. Matsumoto, and A. Fujioka The effect of Quercetin on cell cycle progression and growth of human gastric cancer cells FEBS Lett 260 1990 10 13
7. I.R. Record, J.L. Broadbent, R.A. King, I.E. Dreosti, R.J. Head, and A.L. Tonkin Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro Int J Cancer 72 1997 860 864
8. Y.T. Huang, J.J. Hwang, P.P. Lee, F.C. Ke, J.H. Huang, and C.J. Huang Effects of Luteolin and Quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor Br J Pharmacol 128 1999 999 1010
9. D.R. Ferry, A. Smith, J. Malkhandi, D.W. Fyfe, P.G. deTakats, and D. Anderson Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin Cancer Res 2 1996 659 668
10. R.M. Mohammad, A. Al-Katib, A. Aboukameel, D.R. Doerge, F. Sarkar, and O. Kucuk Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy Mol Cancer Ther 2 2003 1361 1368
11. L. Pegoraro, L. Matera, J. Ritz, A. Levis, A. Palumbo, and G. Biagini Establishment of a Ph1-positive human cell line (BV-173) J Natl Cancer Inst 70 1983 447 453
12. K. Tsuganezawa, N. Kiyokawa, Y. Matsuo, F. Kitamura, N. Toyama-Sorimachi, and K. Kuida Flow cytometric diagnosis of the cell lineage and developmental stage of acute lymphoblastic leukemia by novel monoclonal antibodies specific to human pre B cell receptor Blood 92 1998 4317 4324
13. N. Kiyokawa, Y. Kokai, K. Ishimoto, H. Fujita, J. Fujimoto, and J. Hata Characterization of the common acute lymphoblastic leukemia antigen (CD10) as an activation molecule on mature human B cells Clin Exp Immunol 79 1990 322 327
14. A.R. Chowdhury, S. Sharma, S. Mandal, A. Goswami, S. Mukhopadhyay, and H.K. Majumder Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I Biochem J 366 2002 653 661
15. R. Strick, P.L. Strissel, S. Borgers, S.L. Smith, and J.D. Rowley Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukaemia Proc Natl Acad Sci USA 97 2000 4790 4795
16. L.F. Liu DNA topoisomerase poisons as antitumor drugs Annu Rev Biochem 58 1989 351 375
17. H.M. Beere, C.M. Chresta, A. Alejo-Herberg, A. Skladanowski, C. Dive, and A.K. Larsen Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis Mol Pharmacol 47 1995 986 996
18. D. Chandra, G. Choy, X. Deng, B. Bhatia, P. Daniel, and D.G. Tang Association of active caspase 8 with the mitochondrial membrane during apoptosis: potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death Mol Cell Biol 24 2004 6592 6607
19. P.L. Strissel, R. Strick, J.D. Rowley, and N.J. Zeleznik-Le An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region Blood 92 1998 3793 3803
20. L.M. Martins, P.W. Mesner, T.J. Kottke, G.S. Basi, S. Sinha, and J.S. Tung Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis Blood 90 1997 4283 4296
21. D.W. Lamson, and M.S. Brignall Antioxidants and cancer, part 3: quercetin Altern Med Rev 5 2000 196 208
22. F. Casagrande, and J.M. Darbon Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1 Biochem Pharmacol 61 2001 1205 1215
23. S.J. Su, T.M. Yeh, H.Y. Lei, and N.H. Chow The potential of soybean foods as a chemoprevention approach for human urinary tract cancer Clin Cancer Res 6 2000 230 236
24. D.H. Han, M.S. Denison, H. Tachibana, and K. Yamada Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids Biosci Biotechnol Biochem 66 2002 1479 1487